266 related articles for article (PubMed ID: 25129371)
1. Maximum tumor diameter adjusted to the risk profile predicts biochemical recurrence after radical prostatectomy.
Müller G; Rieken M; Bonkat G; Gsponer JR; Vlajnic T; Wetterauer C; Gasser TC; Wyler SF; Bachmann A; Bubendorf L
Virchows Arch; 2014 Oct; 465(4):429-37. PubMed ID: 25129371
[TBL] [Abstract][Full Text] [Related]
2. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L
BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488
[TBL] [Abstract][Full Text] [Related]
3. Maximum tumor diameter is not an independent prognostic factor in high-risk localized prostate cancer.
van Oort IM; Witjes JA; Kok DE; Kiemeney LA; Hulsbergen-vandeKaa CA
World J Urol; 2008 Jun; 26(3):237-41. PubMed ID: 18265988
[TBL] [Abstract][Full Text] [Related]
4. Larger maximum tumor diameter at radical prostatectomy is associated with increased biochemical failure, metastasis, and death from prostate cancer after salvage radiation for prostate cancer.
Johnson SB; Hamstra DA; Jackson WC; Zhou J; Foster B; Foster C; Song Y; Li D; Palapattu GS; Kunju L; Mehra R; Sandler H; Feng FY
Int J Radiat Oncol Biol Phys; 2013 Oct; 87(2):275-81. PubMed ID: 23886418
[TBL] [Abstract][Full Text] [Related]
5. Maximum tumor diameter: a simple independent predictor for biochemical recurrence after radical prostatectomy.
Fukuhara H; Kume H; Suzuki M; Fujimura T; Enomoto Y; Nishimatsu H; Ishikawa A; Homma Y
Prostate Cancer Prostatic Dis; 2010 Sep; 13(3):244-7. PubMed ID: 20567255
[TBL] [Abstract][Full Text] [Related]
6. Risk-adjusted hazard rates of biochemical recurrence for prostate cancer patients after radical prostatectomy.
Walz J; Chun FK; Klein EA; Reuther A; Graefen M; Huland H; Karakiewicz PI
Eur Urol; 2009 Feb; 55(2):412-19. PubMed ID: 19027223
[TBL] [Abstract][Full Text] [Related]
7. External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores.
Kupelian P; Katcher J; Levin H; Zippe C; Suh J; Macklis R; Klein E
Cancer J Sci Am; 1997; 3(2):78-87. PubMed ID: 9099457
[TBL] [Abstract][Full Text] [Related]
8. The presence of positive surgical margins in patients with organ-confined prostate cancer results in biochemical recurrence at a similar rate to that in patients with extracapsular extension and PSA ≤ 10 ng/ml.
Eminaga O; Hinkelammert R; Titze U; Abbas M; Eltze E; Bettendorf O; Semjonow A
Urol Oncol; 2014 Jan; 32(1):32.e17-25. PubMed ID: 23434425
[TBL] [Abstract][Full Text] [Related]
9. Radical prostatectomy and positive surgical margins: relationship with prostate cancer outcome.
De La Roca RL; Da Cunha IW; Bezerra SM; Da Fonseca FP
Int Braz J Urol; 2014; 40(3):306-15. PubMed ID: 25010296
[TBL] [Abstract][Full Text] [Related]
10. Tumour length of the largest focus predicts prostate-specific antigen-based recurrence after radical prostatectomy in clinically localized prostate cancer.
Mizuno R; Nakashima J; Mukai M; Okita H; Kosugi M; Kikuchi E; Miyajima A; Nakagawa K; Ohigashi T; Oya M
BJU Int; 2009 Nov; 104(9):1215-8. PubMed ID: 19389009
[TBL] [Abstract][Full Text] [Related]
11. In Organ-confined Prostate Cancer, Tumor Quantitation Not Found to Aid in Prediction of Biochemical Recurrence.
Ito Y; Vertosick EA; Sjoberg DD; Vickers AJ; Al-Ahmadie HA; Chen YB; Gopalan A; Sirintrapun SJ; Tickoo SK; Eastham JA; Scardino PT; Reuter VE; Fine SW
Am J Surg Pathol; 2019 Aug; 43(8):1061-1065. PubMed ID: 31107718
[TBL] [Abstract][Full Text] [Related]
12. Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancer.
Lughezzani G; Gallina A; Larcher A; Briganti A; Capitanio U; Suardi N; Lista G; Abrate A; Sangalli MN; Buffi N; Cestari A; Guazzoni G; Rigatti P; Montorsi F
BJU Int; 2013 May; 111(5):723-30. PubMed ID: 22487441
[TBL] [Abstract][Full Text] [Related]
13. Short (≤ 1 mm) positive surgical margin and risk of biochemical recurrence after radical prostatectomy.
Shikanov S; Marchetti P; Desai V; Razmaria A; Antic T; Al-Ahmadie H; Zagaja G; Eggener S; Brendler C; Shalhav A
BJU Int; 2013 Apr; 111(4):559-63. PubMed ID: 22759270
[TBL] [Abstract][Full Text] [Related]
14. Patterns and predictors of early biochemical recurrence after radical prostatectomy and adjuvant radiation therapy in men with pT3N0 prostate cancer: implications for multimodal therapies.
Briganti A; Joniau S; Gandaglia G; Cozzarini C; Sun M; Tombal B; Haustermans K; Hinkelbein W; Shariat SF; Karakiewicz PI; Montorsi F; Van Poppel H; Wiegel T
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):960-7. PubMed ID: 24351411
[TBL] [Abstract][Full Text] [Related]
15. The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients.
Bianchi L; Nini A; Bianchi M; Gandaglia G; Fossati N; Suardi N; Moschini M; Dell'Oglio P; Schiavina R; Montorsi F; Briganti A
Eur Urol; 2016 Jun; 69(6):1142-8. PubMed ID: 26749093
[TBL] [Abstract][Full Text] [Related]
16. The impact of solitary and multiple positive surgical margins on hard clinical end points in 1712 adjuvant treatment-naive pT2-4 N0 radical prostatectomy patients.
Mauermann J; Fradet V; Lacombe L; Dujardin T; Tiguert R; Tetu B; Fradet Y
Eur Urol; 2013 Jul; 64(1):19-25. PubMed ID: 22901983
[TBL] [Abstract][Full Text] [Related]
17. Late biochemical recurrence after radical prostatectomy is associated with a slower rate of progression.
Chow K; Herrera P; Stuchbery R; Peters JS; Costello AJ; Hovens CM; Corcoran NM
BJU Int; 2019 Jun; 123(6):976-984. PubMed ID: 30248237
[TBL] [Abstract][Full Text] [Related]
18. Maximum tumor diameter and the risk of prostate-specific antigen recurrence after radical prostatectomy.
Rose BS; Chen MH; Zhang D; Hirsch MS; Richie JP; Chang SL; Hegde JV; Loffredo MJ; D'Amico AV
Clin Genitourin Cancer; 2014 Oct; 12(5):e173-9. PubMed ID: 24787967
[TBL] [Abstract][Full Text] [Related]
19. Positive surgical margins after minimally invasive radical prostatectomy in patients with pT2 and pT3a disease could be considered pathological upstaging.
Ouzzane A; Rozet F; Salas RS; Galiano M; Barret E; Prapotnich D; Cathelineau X
BJU Int; 2014 Apr; 113(4):586-91. PubMed ID: 23889763
[TBL] [Abstract][Full Text] [Related]
20. Tumor volume, surgical margin, and the risk of biochemical recurrence in men with organ-confined prostate cancer.
Song C; Kang T; Yoo S; Jeong IG; Ro JY; Hong JH; Kim CS; Ahn H
Urol Oncol; 2013 Feb; 31(2):168-74. PubMed ID: 21719325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
